BR112022019688A2 - Extrato de fração de folhas de melissa officinalis e nova composição farmacêutica incluindo o mesmo - Google Patents

Extrato de fração de folhas de melissa officinalis e nova composição farmacêutica incluindo o mesmo

Info

Publication number
BR112022019688A2
BR112022019688A2 BR112022019688A BR112022019688A BR112022019688A2 BR 112022019688 A2 BR112022019688 A2 BR 112022019688A2 BR 112022019688 A BR112022019688 A BR 112022019688A BR 112022019688 A BR112022019688 A BR 112022019688A BR 112022019688 A2 BR112022019688 A2 BR 112022019688A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
same
new pharmaceutical
composition including
melissa officinalis
Prior art date
Application number
BR112022019688A
Other languages
English (en)
Inventor
Young Kim Min
Young Park Byung
Kyu Park Eun
Suk Lee Hee
Soo Yuh Hyung
Original Assignee
Angiolab Inc
Young Kim Min
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020200042856A external-priority patent/KR102229760B1/ko
Priority claimed from KR1020210032830A external-priority patent/KR20220128554A/ko
Application filed by Angiolab Inc, Young Kim Min filed Critical Angiolab Inc
Publication of BR112022019688A2 publication Critical patent/BR112022019688A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)

Abstract

EXTRATO DE FRAÇÃO DE FOLHAS DE MELISSA OFFICINALIS E NOVA COMPOSIÇÃO FARMACÊUTICA INCLUINDO O MESMO. A presente invenção se refere a um extrato de fração de folhas de Melissa officinalis e uma nova composição farmacêutica e uma composição alimentícia que inclui a mesma.
BR112022019688A 2020-04-08 2021-04-07 Extrato de fração de folhas de melissa officinalis e nova composição farmacêutica incluindo o mesmo BR112022019688A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020200042856A KR102229760B1 (ko) 2020-04-08 2020-04-08 멜리사엽 추출물 분획 및 이를 포함하는 신규 약학적 조성물
KR1020210032830A KR20220128554A (ko) 2021-03-12 2021-03-12 멜리사엽 분획 추출물 및 이를 포함하는 신규 약학적 조성물
PCT/KR2021/004375 WO2021206455A1 (ko) 2020-04-08 2021-04-07 멜리사엽 분획 추출물 및 이를 포함하는 신규한 약학적 조성물

Publications (1)

Publication Number Publication Date
BR112022019688A2 true BR112022019688A2 (pt) 2022-11-22

Family

ID=78023771

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022019688A BR112022019688A2 (pt) 2020-04-08 2021-04-07 Extrato de fração de folhas de melissa officinalis e nova composição farmacêutica incluindo o mesmo

Country Status (8)

Country Link
US (1) US20230117155A1 (pt)
EP (1) EP4134091A4 (pt)
JP (1) JP2023521974A (pt)
CN (1) CN115397449A (pt)
AU (1) AU2021253397A1 (pt)
BR (1) BR112022019688A2 (pt)
CA (1) CA3172259A1 (pt)
WO (1) WO2021206455A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021216548A1 (en) * 2020-04-21 2021-10-28 University Of Massachusetts Methods and compositions for treatment of age-related macular degeneration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100336521C (zh) * 2000-12-12 2007-09-12 血管实验室公司 蜜蜂花叶提取物制备抑制血管生成相关疾病药物的用途
KR100645385B1 (ko) * 2005-10-05 2006-11-23 주식회사 안지오랩 비만 억제용 조성물
KR100903030B1 (ko) * 2007-08-23 2009-06-18 주식회사 안지오랩 멜리사엽 추출물 분획 및 이를 포함하는 조성물
KR20140011209A (ko) * 2012-07-18 2014-01-28 한미약품 주식회사 멜리사엽 추출물을 포함하는 혈관신생 또는 ｍｍｐ 활성 매개 질환의 예방 또는 치료용 정제
KR20150035245A (ko) * 2013-09-27 2015-04-06 한미약품 주식회사 멜리사엽 추출물을 포함하는 정제의 제조방법
KR102229760B1 (ko) * 2020-04-08 2021-03-22 주식회사 안지오랩 멜리사엽 추출물 분획 및 이를 포함하는 신규 약학적 조성물

Also Published As

Publication number Publication date
CN115397449A (zh) 2022-11-25
CA3172259A1 (en) 2021-10-14
US20230117155A1 (en) 2023-04-20
EP4134091A4 (en) 2024-01-17
EP4134091A1 (en) 2023-02-15
AU2021253397A1 (en) 2022-11-03
JP2023521974A (ja) 2023-05-26
WO2021206455A1 (ko) 2021-10-14

Similar Documents

Publication Publication Date Title
BR112019001794A2 (pt) composição de cannabis
BR112018004532A2 (pt) uso de akkermansia pasteurizado para o tratamento de distúrbios metabólicos
BR112018013820A2 (pt) análogos de egf(a) com substituintes de ácido graxo
BR112022017573A2 (pt) Composição compreendendo uma avenantramida ou um análogo da mesma com estabilidade melhorada
BR112018070060A2 (pt) composições para tratamento bucal com uma exibição de sabor eficiente
BR112022019688A2 (pt) Extrato de fração de folhas de melissa officinalis e nova composição farmacêutica incluindo o mesmo
BRPI0717458A8 (pt) Utilização cosmética por via oral e/ou parenteral da glicosamina e da associação da glicosamina e pelo menos um composto polifenol, processo cosmético, composição para administração oral, e, complemento alimentar ou alimento funcional
BR112017021191A2 (pt) um extrato de indigo naturalis e um processo para preparar o mesmo
BR112021019262A2 (pt) Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose
BR112017021190A2 (pt) composição farmacêutica e o uso da mesma
PH12019501295A1 (en) Nutritional compositions containing butyrate and/or lactoferrin and uses thereof
BR112017014189A2 (pt) terapia de câncer com um parvovirus combinado com bevacizumabe
BR112021004408A2 (pt) Composição de ração animal e uso da mesma
CL2023001746A1 (es) Composición farmacéutica de agonistas duales de glp 1/glp 2
BR102019017062A8 (pt) Composições tópicas compreendendo pichia anomala e retinol
BR112021025665A2 (pt) Uma preparação que compreende um composto de calixareno e o uso médico do mesmo, alimento, ração ou composição cosmética que compreende um composto de calixareno
BR112019001207A2 (pt) composição vaginal compreendendo uma combinação de estrogênio e vitamina d
BR112015005355A2 (pt) composição prebiótica de tilacoíde
BR102019017344A8 (pt) Composições tópicas compreendendo pichia anomala e n-acetil glicosamina
CL2023001745A1 (es) Composición farmacéutica de agonistas duales de glp-1/glp-2
CL2023001747A1 (es) Composición farmacéutica de agonistas duales de glp-1/glp-2
BR112021004464A8 (pt) composição de ração animal e uso da mesma
BR112018006170B8 (pt) Método e composição para clareamento de pele usando um extrato de cultura celular de earliella scabrosa e seu uso
BR112016029619A2 (pt) novas fluoroquinolonas e sesu usos no tratamento de infecções bacterianas
BR112023003540A2 (pt) Composição

Legal Events

Date Code Title Description
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]